Pascoe Richard W - Insider Stock Trading - OpenInsider

CIK: 1343266 - Address: C/O Seelos Therapeutics, Inc., 300 Park Avenue, 2Nd Floor, New York, NY 10022

11 results

TC	Stat	Stk	Ins	Fil	+d	+w	+m	+q	+h	+y	avg
P	%ret	2	1	4	-1	1	-5	3	-5	-6	-2
P	%wins				25	75	25	25	50	33	39

Filing Date	T Date	Ticker	Issuer	Inc	Sector	Ind	Industry	Owner	oSt	Rel	Title	T	TVal	Price	L	Qty	oc	Own	H	r2y	r1y	r6m	r3m	r6w	r3w	r7d	r3d	f1d	f1w	f1m	f3m	f6m	f1y
3/13/23 07:53	3/9/23	ZVRA	Zevra Therapeutics, Inc.	DE	Health	Drug	Pharmaceutical Preparations	Pascoe Richard W	FL	DO	CEO	P	42	4.20	0	10	50	30	D
1/13/23 17:27	1/13/23	KMPH	Kempharm, Inc	DE	Health	Drug	Pharmaceutical Preparations	Pascoe Richard W	FL	DO	CEO	P	52	5.44	0	10	91	20	D
5/18/22 17:25	5/18/22	KMPH	Kempharm, Inc	DE	Health	Drug	Pharmaceutical Preparations	Pascoe Richard W	FL	DO	Exec CB	P	25	4.92	0	5	152	8	D
11/30/21 19:42	11/30/21	KMPH	Kempharm, Inc	DE	Health	Drug	Pharmaceutical Preparations	Pascoe Richard W	FL	DO	Exec CB	P	12	7.88	0	2	84	3	D
3/30/21 18:28	3/30/21	HSTO	Histogen Inc.	DE	Health	Drug	Pharmaceutical Preparations	Pascoe Richard W	CA	DO	P,CEO,Di	P	23	1.14	0	20	200	30	D
12/7/20 16:06	12/3/20	HSTO	Histogen Inc.	DE	Health	Drug	Pharmaceutical Preparations	Pascoe Richard W	CA	DO	P,CEO,Di	P	12	1.24	0	10	New	10	D
8/18/20 16:55	8/18/20	KMPH	Kempharm, Inc	DE	Health	Drug	Pharmaceutical Preparations	Pascoe Richard W	FL	D		P	6	0.6352	0	10	54	29	D
12/22/14 16:32	12/22/14	APRI	Apricus Biosciences, Inc.	NV	Health	Drug	Pharmaceutical Preparations	Pascoe Richard W	CA	DO	CEO	P	10	1.02	0	10	27	47	D	-55	-50	-57	-40	-36	-16	-16	-12	-1	0	26	106	72	5
10/24/14 14:41	10/22/14	APRI	Apricus Biosciences, Inc.	NV	Health	Drug	Pharmaceutical Preparations	Pascoe Richard W	CA	DO	CEO	P	18	1.51	0	12	48	37	D	-50	-22	-31	-20	-15	9	19	-4	3	1	-13	-22	3	-11
5/24/13 16:49	5/23/13	APRI	Apricus Biosciences, Inc.	NV	Health	Drug	Pharmaceutical Preparations	Pascoe Richard W	CA	DO	CEO	P.d	100	2.85	2	35	New	35	D	-48	0	17	2	-13	0	5	-21	-4	6	-9	-15	-26	-12
6/13/11 06:16	6/10/11	SOMX	Somaxon Pharmaceuticals, Inc.	DE	Health	Drug	Pharmaceutical Preparations	Pascoe Richard W	CA	DO	P,CEO	P	25	2.25	1	11	6	208	D	108	-55	-23	-24	-19	-16	-3	-4	-1	-3	-22	-59	-67

D	Derivative transaction in filing (usually option exercise)
M	Multiple transactions in filing; earliest reported transaction date and weighted average transaction price
A	Amended filing
E	Error detected in filing

S - Sale	Sale of securities on an exchange or to another person
S - Sale+OE	Sale of securities on an exchange or to another person (after option exercise)
F - Tax	Payment of exercise price or tax liability using portion of securities received from the company
P - Purchase	Purchase of securities on an exchange or from another person

Return to top

Contact